Anesthetic management of a patient with hypertrophic cardiomyopathy on mavacamten
Annals of Case Reports and Medical Images · 31.12.2025 · 2 (2)
DOI: 10.52768/3065-7849/1032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Case Reports and Medical Images, online erschienen am 31.12.2025. Verfasst von Luca Zazzeron.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric Left Ventricular (LV) hypertrophy, resulting in a dynamic LV Outflow Tract (LVOT) obstruction that can cause hemodynamic collapse.
Zitieren
APA
Zazzeron, L. (2025). Anesthetic management of a patient with hypertrophic cardiomyopathy on mavacamten. Annals of Case Reports and Medical Images, 2(2). https://doi.org/10.52768/3065-7849/1032
Vancouver
Zazzeron L. Anesthetic management of a patient with hypertrophic cardiomyopathy on mavacamten. Annals of Case Reports and Medical Images. 2025;2(2). doi:10.52768/3065-7849/1032
BibTeX
@article{Zazzeron2025,
author = {Zazzeron, Luca},
title = {Anesthetic management of a patient with hypertrophic cardiomyopathy on mavacamten},
journal = {Annals of Case Reports and Medical Images},
year = {2025},
volume = {2},
number = {2},
doi = {10.52768/3065-7849/1032}
}
EUVIMED